rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Matthew S. McIlwain

Director

Company insider

Files Form 4 as: Director, Nautilus Biotechnology; Director and 10% owner, Smartsheet; Director and 10% owner, Apptio; Director and 10% owner, Isilon Systems.

In numbers

Trades disclosed
246
Buys
13
Sells
24
Bought
$4.0M
Sold
$437.1M
Companies
4
Companies where not an officer
4
First trade
20 Dec 2006
Last trade
18 Jun 2026
Last filed
22 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NAUT Nautilus BiotechnologyDirector · Life-science tools · last 18 Jun 20264 buys · 0 sells
SmartsheetDirector, 10% owner · last 22 Jan 20253 buys · 13 sells
ApptioDirector, 10% owner · last 10 Jan 20190 buys · 7 sells
Isilon SystemsDirector, 10% owner · last 17 Dec 20106 buys · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
18 Jun 2026filed 22 Jun 2026NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—45,000 at $0.00filing
18 Jun 2026filed 22 Jun 2026NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—45,000 at $0.00filing
23 Jun 2025filed 25 Jun 2025NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—45,000 at $0.00filing
22 Jan 2025filed 24 Jan 2025Smartsheetoption or derivativeSEC FORM 4 Code D—4,864 at $0.00filing
22 Jan 2025filed 24 Jan 2025SmartsheetSEC FORM 4 Code D$7.4M131,122 at $56.50filing
18 Jun 2024filed 18 Jun 2024Smartsheetoption or derivativeSEC FORM 4 Code A—4,864 at $0.00filing
14 Jun 2024filed 18 Jun 2024Smartsheetoption or derivativeSEC FORM 4 Code M—4,401 at $0.00filing
14 Jun 2024filed 18 Jun 2024SmartsheetSEC FORM 4 Code M—4,401filing
14 Jun 2024filed 17 Jun 2024NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—45,000 at $0.00filing
12 Dec 2023filed 14 Dec 2023SmartsheetSEC FORM 4 Code G—7,000 at $0.00filing
16 Jun 2023filed 20 Jun 2023Smartsheetoption or derivativeSEC FORM 4 Code A—4,401 at $0.00filing
16 Jun 2023filed 20 Jun 2023Smartsheetoption or derivativeSEC FORM 4 Code M—5,162 at $0.00filing
16 Jun 2023filed 20 Jun 2023SmartsheetSEC FORM 4 Code M—5,162filing
15 Jun 2023filed 16 Jun 2023NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—45,000 at $0.00filing
27 Feb 2023filed 27 Feb 2023SmartsheetSEC FORM 4 Code G—5,500 at $0.00filing
17 Jun 2022filed 22 Jun 2022Smartsheetoption or derivativeSEC FORM 4 Code M—2,952 at $0.00filing
17 Jun 2022filed 22 Jun 2022Smartsheetoption or derivativeSEC FORM 4 Code A—5,162 at $0.00filing
17 Jun 2022filed 22 Jun 2022SmartsheetSEC FORM 4 Code M—2,952filing
15 Jun 2022filed 16 Jun 2022NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—86,467 at $0.00filing
18 Mar 2022filed 21 Mar 2022SmartsheetSEC FORM 4 Bought$454K9,157 at $49.53filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4
Not placed33

Buys in green, sells in red, by the company’s sector.

Related people

Farzad NazemDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Matthew L. PosardDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Karen AkinsanyaOfficer · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Epperly Melissa BDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
AH Bio Fund II, L.P.10% owner · 10% owner at Nautilus Biotechnology, filing Form 4 there in the last year